Pub Award

Press Release

Dr. Schena receives publication award

Sunnyvale, CA, January 21, 2003 – On January 10th, Thomson Corporation, the world’s leading information resource, announced that TeleChem’s Visiting Scholar Dr. Mark Schena published the most highly cited scientific paper in the history of his field. Thomson’s ISI Division tracks scientific research papers as an indicator of their scientific impact.

The Essential Science Indicators chose a number of important research areas including the Arabidopsis field, which published Dr. Schena’s pioneering Science paper on microarrays. In the study, a total of 18,180 papers from 722 scientific journals, representing 29,339 authors in 83 countries and 3,272 institutions were assembled and ranked according to the number of journal citations over a ten year period spanning 1992-2002. Dr. Schena’s paper “Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray” published in Science magazine in 1995 (Science 270, 467-470) received a total of 1,287 citations, ranking it number one among the 18,180 papers examined. The next closest publications from the INRA in France, the California Institute of Technology in Pasadena, and Harvard Medical School in Boston received 722, 535 and 529 citations, respectively.

“This is a totally unexpected award”, said Dr. Schena. “We knew that the paper was well received, but to be rated number one among so many fine publications is simply amazing. This is a great day for the Arabidopsis field, microarrays and TeleChem. The entire Stanford research team deserves praise for this accomplishment.”

About TeleChem International, Inc.
TeleChem is a diversified business organized into three corporate divisions: Life Sciences, Chemicals, and Diagnostics. The Life Sciences ArrayIt® Division provides a complete line of products and services for the microarray industry, a high-tech sector that uses tiny glass “chips” to explore the human genome. Microarray technology is speeding disease analysis, drug discovery, and crop plant development. The microarray products are sold under the ArrayIt® brand name, and include key patents (e.g. US 6,101,946) that protect the company’s core microarray manufacturing technology used in more than 10,000 corporate and university laboratories worldwide. The Chemicals Division provides import and export services and government contract work in the area of industrial chemicals including raw materials for plastics, water-soluble fertilizers, and cleaning compounds. The Chemicals Division enjoys expanding sales and profits, and provides financial support for research and development. The Diagnostics Division NGS-ArrayIt, Inc. has key patent filings in the areas of genotyping and medical diagnostics, and provides its tools and technologies to public health laboratories and other agencies involved in human disease analysis. NGS-ArrayIt plans to launch a new line of disease tests for sickle cell anemia, cystic fibrosis, hereditary hearing loss and other treatable diseases in the near future.

Media Contact
Paul Haje
Director of Public Relations
408-744-1331
Email paul@ArrayIt®.com